University of Oklahoma College of Medicine

Oklahoma City, Oklahoma 73190

1 studies enrolling now · 54 studies all time

What they study most

Bladder Cancer, Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Gestational Trophoblastic Tumor, Hypercalcemia of Malignancy, Lung Cancer, Lupus Erythematosus, Systemic, Lymphedema, Metastatic Cancer, Ovarian Cancer, Pain

Studies at this site

• Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2 — Recruiting now
• A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus — Running, not enrolling
• Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA — Completed
• Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer — Completed
• Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer — Stopped early
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus — Stopped early
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus — Completed
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer — Completed
• Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
• Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) — Completed
• Eflornithine in Treating Patients With Bladder Cancer — Completed
• Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer — Status unconfirmed
• Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers — Completed
• Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer — Completed
• Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus — Stopped early
• Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix — Completed
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer — Stopped early
• Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer — Completed
• Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva — Completed
• Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer — Completed
• Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
• Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer — Completed
• Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
• Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum — Completed
• Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy — Completed
• Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer — Completed
• Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer — Completed
• Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia — Completed
• Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer — Stopped early
• Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer — Stopped early
• Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer — Stopped early
• Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer — Completed
• Chemotherapy in Treating Patients With Sarcoma of the Uterus — Completed
• Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva — Stopped early
• Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer — Completed
• Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy — Completed
• Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer — Completed
• Quality of Life in Survivors of Gynecologic Cancer — Completed
• Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer — Completed
• Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer — Completed
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer — Completed
• Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer — Stopped early
• Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix — Stopped early
• Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix — Stopped early
• Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer — Stopped early
• Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus — Stopped early
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer — Stopped early
• Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus — Stopped early
• Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus — Stopped early
• Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer — Stopped early